Frontlight ResearchEarly access
Trial site
Hainan Cancer Hospital
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Diffuse large B-cell lymphoma2 trials
- Chronic lymphocytic leukaemia1 trial
- Gastric and oesophageal cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Early phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed3 trials
- Not yet recruiting3 trials
- Lead sponsor
- BeiGene3 trials
- Akeso1 trial
- Amgen1 trial
- Antengene Biologics Limited1 trial
- Binhui Biopharmaceutical Co., Ltd.1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Gastric and oesophageal cancer1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026